Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14796-7 Insulin SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Insulin [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14796-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Insulin SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
14797-5 Iron Imp Ser/Plas Pt Nom &nbsp; &nbsp; ACTIVE Iron [Interpretation] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14797-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Iron SerPl-Imp &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Chemistry; Fe; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.26 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
14798-3 Iron SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Iron [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14798-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Iron SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Fe; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14799-1 Iron SRat Urine 24H Qn &nbsp; &nbsp; ACTIVE Iron [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/d &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14799-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Iron 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Chemistry; Fe; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/(24.h) &nbsp; &nbsp; &nbsp; 0
148-7 Cephalexin Susc Isolate Pt Qn MLC &nbsp; ACTIVE Cephalexin [Susceptibility] by Minimum lethal concentration (MLC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 148-7 &nbsp; MLC &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cephalexin Islt MLC &nbsp; &nbsp; &nbsp; Y &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefadine; GRACEF; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Keflex; Losporal; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Palitrex; Point in time; QNT; Quan; Quant; Quantitative; Random; Salitex; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
1480-3 Galactose^1H post 40 g galactose PO MCnc Bld Pt Qn &nbsp; &nbsp; ACTIVE Galactose [Mass/volume] in Blood --1 hour post 40 g galactose PO &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1480-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Galactose 1h p 40 g Gal PO Bld-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 1 hour; 1.0Hr; 1h p 40 g Gal PO; 60 min; 60 minutes; 60M; 60min; After; Blood; Cerebrose; CHEMISTRY.CHALLENGE TESTING; Galactose tolerance test; Level; Mass concentration; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.4 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
14800-7 Iron binding capacity SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Iron binding capacity [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14800-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 TIBC SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Bind; Chemistry; dTIBC; Fe; IBC; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TIBC; Total iron binding 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14801-5 Iron saturation SFr Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Iron saturation [Molar fraction] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; (Fe/TIBC)/100 &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14801-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Iron Satn SFr SerPl &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Fe; FE/TIBC; Iron Satn; Iron/Iron binding capacity.total; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SAT; Satn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance fraction; Transferrin saturation 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
14802-3 Isopropanol SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Isopropanol [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14802-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Isopropanol SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 2-propanol; c615; DRUG/TOXICOLOGY; Drugs; Isopropyl alcohol; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14803-1 Lactate dehydrogenase CCnc Body fld Pt Qn Reaction: lactate to pyruvate &nbsp; ACTIVE Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction &nbsp; MIN DefinitionDescription &nbsp; &nbsp; arb U/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14803-1 &nbsp; Reaction: lactate to pyruvate &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 LDH Fld L to P-cCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; Fl; Fld; FLU; Fluid; L to P; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; Tumor marker; UniversalLabOrders 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; U/L &nbsp; &nbsp; &nbsp; 0
14804-9 Lactate dehydrogenase CCnc Ser/Plas Pt Qn Reaction: lactate to pyruvate &nbsp; ACTIVE Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction &nbsp; MIN DefinitionDescription &nbsp; &nbsp; arb U/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14804-9 &nbsp; Reaction: lactate to pyruvate &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 LDH SerPl L to P-cCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L to P; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; U/L &nbsp; &nbsp; &nbsp; 0
14805-6 Lactate dehydrogenase CCnc Ser/Plas Pt Qn Reaction: pyruvate to lactate &nbsp; ACTIVE Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction &nbsp; MIN DefinitionDescription &nbsp; &nbsp; arb U/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14805-6 &nbsp; Reaction: pyruvate to lactate &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 LDH SerPl P to L-cCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; L-lactate; L-lactate dehydrogenase; P to L; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; React; Rxn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker; UniversalLabOrders 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; U/L &nbsp; &nbsp; &nbsp; 0
14806-4 Lactose.PO Mass Dose Pt Qn &nbsp; &nbsp; ACTIVE Lactose.PO [Mass] of Dose &nbsp; MIN DefinitionDescription &nbsp; &nbsp; g &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUGDOSE &nbsp; 14806-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Lactose PO Dose &nbsp; &nbsp; &nbsp; Y &nbsp; Dose med or substance; DRUG DOSES; Lactose PO; Point in time; QNT; Quan; Quant; Quantitative; Random 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; g &nbsp; &nbsp; &nbsp; 0
14807-2 Lead SCnc Bld Pt Qn &nbsp; &nbsp; ACTIVE Lead [Moles/volume] in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14807-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Lead Bld-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Blood; DRUG/TOXICOLOGY; Drugs; Level; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14808-0 Lead SCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Lead [Moles/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14808-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Lead Ur-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14809-8 Lead SRat Urine 24H Qn &nbsp; &nbsp; ACTIVE Lead [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/d &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14809-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Lead 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; Painter's colic; PB; Plumbism; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/(24.h) &nbsp; &nbsp; &nbsp; 0
1481-1 Galactose^2H post 40 g galactose PO MCnc Bld Pt Qn &nbsp; &nbsp; ACTIVE Galactose [Mass/volume] in Blood --2 hours post 40 g galactose PO &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1481-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Galactose 2h p 400 g Gal PO Bld-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 120 min; 120 minutes; 120min; 2 hours; 2h p 400 g Gal PO; After; Blood; Cerebrose; CHEMISTRY.CHALLENGE TESTING; Galactose tolerance test; Level; Mass concentration; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.4 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mg/dL &nbsp; &nbsp; &nbsp; 0
14810-6 Leukocytes NCnc Bronchial Pt Qn Manual count &nbsp; ACTIVE Leukocytes [#/volume] in Bronchial specimen by Manual count &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14810-6 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 WBC # Bronch Manual &nbsp; &nbsp; &nbsp; Y &nbsp; #; ABS; absolute; absolutes; Bro; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells 2.19 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
14811-4 Leukocytes NCnc Pericard fld Pt Qn Manual count &nbsp; ACTIVE Leukocytes [#/volume] in Pericardial fluid by Manual count &nbsp; MIN DefinitionDescription &nbsp; &nbsp; 10*6/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; HEM/BC &nbsp; 14811-4 &nbsp; Manual count &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 WBC # Pcar Manual &nbsp; &nbsp; &nbsp; Y &nbsp; #; ABS; absolute; absolutes; Cardio; Cardiology; Cnt; Count; Count/volume; CT; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; /uL &nbsp; &nbsp; &nbsp; 0
14812-2 Lidocaine SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Lidocaine [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14812-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Lidocain SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; c232; c251; CLID; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Xylocaine 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14813-0 Lipoprotein.alpha SCnc Ser/Plas Pt Qn Electrophoresis &nbsp; ACTIVE Lipoprotein.alpha [Moles/volume] in Serum or Plasma by Electrophoresis &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14813-0 &nbsp; Electrophoresis &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 HDL SerPl Elph-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Alfa; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; HDL; HDL particle concentration; HDL particle number; High density lipoproteins; Level; Lip; Lipoprot; Lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14814-8 Lipoprotein.beta SCnc Ser/Plas Pt Qn Electrophoresis &nbsp; ACTIVE Lipoprotein.beta [Moles/volume] in Serum or Plasma by Electrophoresis &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14814-8 &nbsp; Electrophoresis &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 LDL SerPl Elph-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; B; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; LDL; LDL particle concentration; LDL particle number; Level; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.4 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14815-5 Lipoprotein.beta SCnc Ser/Plas Pt Qn Calculated &nbsp; ACTIVE Lipoprotein.beta [Moles/volume] in Serum or Plasma by calculation &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14815-5 &nbsp; Calculated &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 LDL SerPl Calc-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; B; Calc; Calculation; Chemistry; LDL; LDL particle concentration; LDL particle number; Level; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mmol/L &nbsp; &nbsp; &nbsp; 0
14816-3 Lipoprotein.pre-beta SCnc Ser/Plas Pt Qn Electrophoresis &nbsp; ACTIVE Lipoprotein.pre-beta [Moles/volume] in Serum or Plasma by Electrophoresis &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14816-3 &nbsp; Electrophoresis &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 VLDL SerPl Elph-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; B; Before; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; LDL particle concentration; LDL particle number; Level; Lip; Lipoprot; Lipoproteins; LP; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Very low density lipoproteins; VLDL; VLDL particle concentration; VLDL particle number 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14817-1 LORazepam SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE LORazepam [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14817-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 LORazepam SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Addiction; Ativan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
108,248 results found